These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26427697)

  • 1. The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators.
    Gravel G; Niccoli P; Rohmer V; Moulin G; Borson-Chazot F; Rousset P; Pasco-Papon A; Marcus C; Dubrulle F; Gouya H; Bidault F; Dupas B; Gabrillargues J; Caumont-Prim A; Hernigou A; Gimenez-Roqueplo AP; Halimi P
    Eur Radiol; 2016 Jun; 26(6):1696-704. PubMed ID: 26427697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
    Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography.
    Neves F; Huwart L; Jourdan G; Reizine D; Herman P; Vicaut E; Guichard JP
    AJNR Am J Neuroradiol; 2008 May; 29(5):883-9. PubMed ID: 18339724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck paragangliomas: improved tumor detection using contrast-enhanced 3D time-of-flight MR angiography as compared with fat-suppressed MR imaging techniques.
    van den Berg R; Verbist BM; Mertens BJ; van der Mey AG; van Buchem MA
    AJNR Am J Neuroradiol; 2004 May; 25(5):863-70. PubMed ID: 15140737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.
    McCrary HC; Babajanian E; Calquin M; Carpenter P; Casazza G; Naumer A; Greenberg S; Kohlmann W; Cannon R; Monroe MM; Hunt JP; Buchmann L
    JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):641-646. PubMed ID: 31194233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and follow-up strategies for patients with head and neck paraganglioma.
    Richter S; Pacak K; Kunst HPM; Januszewicz A; Nölting S; Remde H; Robledo M; Eisenhofer G; Timmers HJLM; Pamporaki C
    Eur J Endocrinol; 2024 Sep; 191(4):389-398. PubMed ID: 39303070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of MR angiography techniques in the detection of head and neck paragangliomas.
    van den Berg R; Schepers A; de Bruïne FT; Liauw L; Mertens BJ; van der Mey AG; van Buchem MA
    Eur J Radiol; 2004 Dec; 52(3):240-5. PubMed ID: 15544901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
    Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
    Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.
    Chen H; Zhu W; Li X; Xue L; Wang Z; Wu H
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):953-960. PubMed ID: 28255624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of chromogranin A in SDHx-related paragangliomas.
    Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
    Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison between
    Heimburger C; Veillon F; Taïeb D; Goichot B; Riehm S; Petit-Thomas J; Averous G; Cavalcanti M; Hubelé F; Chabrier G; Namer IJ; Charpiot A; Imperiale A
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):979-987. PubMed ID: 28050631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenotype of
    Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
    Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.
    Daniel E; Jones R; Bull M; Newell-Price J
    Eur J Endocrinol; 2016 Dec; 175(6):561-570. PubMed ID: 27634942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Pepponi M; Berti V; Fasciglione E; Montanini F; Canu L; Hubele F; Abenavoli E; Briganti V; Rapizzi E; Charpiot A; Taieb D; Pacak K; Goichot B; Imperiale A
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2684-2694. PubMed ID: 38687372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.
    Lepoutre-Lussey C; Caramella C; Bidault F; Déandreis D; Berdelou A; Al Ghuzlan A; Hartl D; Borget I; Gimenez-Roqueplo AP; Dumont F; Deschamps F; Nascimento C; Lumbroso J; Guillaud Bataille M; Schlumberger M; Baudin E; Leboulleux S
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):868-76. PubMed ID: 25676472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
    Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
    Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
    Richter S; Qiu B; Ghering M; Kunath C; Constantinescu G; Luths C; Pamporaki C; Bechmann N; Meuter L; Kwapiszewska A; Deutschbein T; Nölting S; Peitzsch M; Robledo M; Prejbisz A; Pacak K; Gudziol V; Timmers HJLM; Eisenhofer G
    Endocr Relat Cancer; 2022 Mar; 29(4):213-224. PubMed ID: 35171114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial paraganglioma syndrome: applying genetic screening in otolaryngology.
    Dziegielewski PT; Knox A; Liu R; Hung RW; Harris J
    J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):646-53. PubMed ID: 21144359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.